Heart failure drug shows promise in rebuilding damaged hearts
NCT ID NCT07472595
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether the drug vericiguat can help reverse harmful changes in the heart's shape and function in people with heart failure. Researchers used advanced ultrasound techniques to measure heart size and pumping ability in 40 participants. The goal was to see if vericiguat could improve heart structure and function beyond standard treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Division of Cardiology, Department of Medicine and Therapeutics Faculty of Medicine, The Chinese University of Hong Kong
Hong Kong, New Territories, Sha Tin, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart failure care gets a Check-Up: study tests if sharing guidelines boosts treatment
- Could eccentric exercise be the key to stronger hearts?
- AI-Powered patch could replace ultrasound for heart checkups
- Smartwatch study aims to keep heart failure patients out of hospital
- Heart-Kidney hope: new drug trial for High-Risk patients
- New device aims to ease heart failure symptoms by stimulating blood pressure sensors